Suchergebnisse - "Challener, Douglas W"

PubPharm (4)

1

Utility of Follow-up Coronavirus Disease 2019 (COVID-19) Antigen Tests After Acute Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Healthcare Personnel

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Tande, A. | Swift, M. | Challener, D. | +5

2

Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-Imdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease 2019

enthalten in: Mayo Clinic proceedings | 2022

von O'Horo, J. | Challener, D. | Anderson, R. | +8

3

Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research

enthalten in: Mayo Clinic proceedings | 2021

von O'Horo, J. | Cerhan, J. | Cahn, E. | +75

CommentIn: Mayo Clin Proc. 2021 Apr;96(4):1092-1093. - PMID 33814077

4

Incidence and Effects of Seasonality on Nonpurulent Lower Extremity Cellulitis After the Emergence of Community-Acquired Methicillin-Resistant Staphylococcus aureus

enthalten in: Mayo Clinic proceedings | 2017

von Marcelin, J. | Challener, D. | Tan, E. | +2

1
[1]